Public Company News & Press Release Distribution

Everest Medicines Will Participate in a Clinical Trial with Gilead and MSD to Evaluate Trodelvy® in Combination with KEYTRUDA® (pembrolizumab) in First-Line Metastatic Non-Small Cell Lung Cancer

SHANGHAI, Jan. 10, 2022 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), today announced it will participate in a study pursuant to a clinical trial collaboration between Gilead and MSD (Merck & Co., Inc., Kenilworth, N...

2022-01-10 21:35 5451

Invitation to Autoliv's Q4, 2021 Earnings Call

STOCKHOLM, Jan. 10, 2022 /PRNewswire/ -- Autoliv Inc., plans to publish its Financial Report for the fourth quarter 2021 onFriday, January 28, 2022 at 12:00 Central European Time (CET). The report will be available at www.autoliv.com In addition, a teleconference will take place the same day. T...

2022-01-10 21:22 2885

Bigtincan Announces Bigtincan for Salesforce on Salesforce AppExchange, the World's Leading Enterprise Cloud Marketplace

Bigtincan's customers can now benefit from a powerful recommendation engine WALTHAM, Mass., Jan. 10, 2022 /PRNewswire/ -- Bigtincan® (ASX:BTH), a global leader in sales enablement automation, today announced the general availability of Bigtincan for Salesforce on Salesforce AppExchange, empoweri...

2022-01-10 21:12 2174

Bigtincan Announces Bigtincan for Salesforce on Salesforce AppExchange, the World's Leading Enterprise Cloud Marketplace

Bigtincan's customers can now benefit from a powerful recommendation engine WALTHAM, Mass., Jan. 10, 2022 /PRNewswire/ -- Bigtincan® (ASX:BTH), a global leader in sales enablement automation, today announced the general availability of Bigtincan for Salesforce on Salesforce AppExchange, empoweri...

2022-01-10 21:12 2685

Clinical study on Bactiguard's endotracheal tube now published - shows significant reduction of ventilator-associated pneumonia

STOCKHOLM, Jan. 10, 2022 /PRNewswire/ -- The VITAL study, by Professor Pierre Damas and his team, is now published in the well renowned journal Annals of Intensive Care. The study shows a 53% reduction of ventilator-associated pneumonia with Bactiguard's endotracheal tube. It was presented for th...

2022-01-10 20:57 2389

Executive Team Hires at SOPHiA GENETICS to Enhance BioPharma Business

BOSTON and LAUSANNE, Switzerland, Jan. 10, 2022 /PRNewswire/ -- SOPHiA GENETICS SA (Nasdaq: SOPH), the creator of a global data pooling and knowledge sharing platform that advances data-driven medicine, announced key additions to their leadership team with the hiring of Peter Casasanto as Chief B...

2022-01-10 20:28 3069

Roundup from Tuya Smart Booth at 2022 CES

LAS VEGAS, Jan. 10, 2022 /PRNewswire/ -- Every January, the annual CES (Consumer Electronics Show) inLas Vegas draws top business professionals from a range of sectors around the world to promote the future of consumer technology. At this year's show, from January 5 through 7, Tuya Smart (NYSE: T...

2022-01-10 20:00 3608

Roundup from Tuya Smart Booth at 2022 CES

Clarivate Announces Change in Leadership Structure

LONDON, Jan. 10, 2022 /PRNewswire/ -- Clarivate plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced that as part of its One Clarivate Vision to put even greater focus on its customers and solutions, effectiveFebruar...

2022-01-10 20:00 2794

ChipMOS REPORTS 19.1% YoY INCREASE IN FY21 REVENUE; 3.4% YoY INCREASE IN DECEMBER 2021 MONTHLY REVENUE; 7.6% YoY INCREASE IN 4Q21 QUARTERLY REVENUE

HSINCHU, Jan. 10, 2022 /PRNewswire/ -- ChipMOS TECHNOLOGIES INC. ("ChipMOS" or the "Company") (Taiwan Stock Exchange: 8150 and NASDAQ: IMOS), an industry leading provider of outsourced semiconductor assembly and test services ("OSAT"), today re...

2022-01-10 19:00 4938

China Telecom's Annual Report Received 20 Gold Awards in Total Together with Two Grand Awards in International ARC Awards

HONG KONG, Jan. 10, 2022 /PRNewswire/ -- China Telecom Corporation Limited ("China Telecom" or "the Company"; HKEx: 00728; SSE: 601728) is pleased to announce that the print and online versions of its 2020 Annual Report " Digitalising the Future" received 11 gold awards in total in this year's In...

2022-01-10 17:21 6900

China Telecom's Annual Report Received 20 Gold Awards in Total Together with Two Grand Awards in International ARC Awards

GoodWe rebrands, highlighting the role of smart tech in transforming the future of energy

SUZHOU, China, Jan. 10, 2022 /PRNewswire/ -- GoodWe has refreshed its brand in line with the evolution of the global new energy space, emphasizing on collaboration and digitalization. At the core of this new brand identity is GoodWe's commitment to harnessing smart tech to drive the global energy...

2022-01-10 16:30 5190

GoodWe rebrands, highlighting the role of smart tech in transforming the future of energy

Clarivate Identifies Seven Potential Blockbuster Drugs in Annual Drugs to Watch Report

Despite the challenges of pandemic disruptions, drug developers advance promising therapies for conditions, including Alzheimer's, diabetes and asthma Report also examines key therapeutic development areas to watch including mRNA, CRISPR, AI-driven drug discovery and more LONDON, Jan. 10, 2022 /...

2022-01-10 16:00 3395

OneConnect Inks New Strategic Partnership Agreement with Chengfang Financial Technology

SHANGHAI, Jan. 9, 2022 /PRNewswire/ -- OneConnect Financial Technology Co., Ltd. (NYSE: OCFT) ("OneConnect"), a leading technology-as-a-service platform for financial institutions has today announced it has entered into a strategic partnership with Chengfang Financial Technology Co. Ltd., (abbrev...

2022-01-10 11:00 5465

JW Therapeutics Announces Two Appointments to Strengthen R&D Capability and Pipeline Building

SHANGHAI, Jan. 10, 2022 /PRNewswire/ -- JW Therapeutics (HKEx: 2126), an independent, innovative biotechnology company focusing on developing, manufacturing and commercializing cell immunotherapy products, recently announced the appointments of Dr.Shaun Paul Cordoba as Chief Scientific Officer (...

2022-01-10 09:30 4803

Ascletis Announces U.S. IND Filing for In-House Developed Oral PD-L1 Small Molecule Inhibitor ASC61 for Treatment of Advanced Solid Tumors

HANGZHOU, China and SHAOXING, China, Jan. 10, 2022 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672) announces today the filing of the U.S. Investigational New Drug (IND) application for in-house developed oral PD-L1 small molecule inhibitor, ASC61, for the treatment of advanced solid tumors. AS...

2022-01-10 08:30 4540

In the Era of the Boom of the Property Management Industry, Desun Services Adopts a Differentiated Approach

CHENGDU, China, Jan. 10, 2022 /PRNewswire/ -- Nowadays, property developers are taking on unprecedented challenges. Under the multiple control measures such as the Three Red Lines policy and centralized land supply, the development of property developers is once again put on hold, leaving the cap...

2022-01-10 07:59 6993

In the Era of the Boom of the Property Management Industry, Desun Services Adopts a Differentiated Approach

USI Plans to Mass-Produce IGBT and SiC Power Modules for Electric Vehicle Inverters in 2022

SHANGHAI, Jan. 10, 2022 /PRNewswire/ -- With the rapid growth of the electric vehicle market, USI (SSE: 60131) has begun to lay out the assembly and testing of power modules for major international power semiconductor suppliers in recent years. Recently, USI won the favor of several European, Ame...

2022-01-10 07:00 5135

HHI Group and ABS to collaborate on real-life trials of autonomous ship technologies

LAS VEGAS, Jan. 9, 2022 /PRNewswire/ -- Avikus, Hyundai Heavy Industries (HHI) Group's subsidiary specializing in autonomous navigation technologies for ships, partners with theAmerican Bureau of Shipping (ABS) to collaborate on real-life trials of autonomous ship technologies.

2022-01-09 16:00 4482

HHI Group and ABS to collaborate on real-life trials of autonomous ship technologies

CanSinoBIO Announces Approval for its MCV4 Product Menhycia™ in China

TIANJIN, China, Jan. 9, 2022 /PRNewswire/ -- CanSino Biologics Inc. ("CanSinoBIO") (SSE: 688185, HKEX: 06185) announced that the National Medical Products Administration ofChina ("NMPA") granted approval for its ACYW135 Meningococcal Conjugate Vaccine (CRM197) ("MCV4", trade name: Menhycia™), ma...

2022-01-09 10:09 4812

SK Telecom, SK Square and SK hynix Launch 'SK ICT Alliance' for Synergies

LAS VEGAS, Jan. 8, 2022 /PRNewswire/ -- At CES 2022, SK Telecom, SK Square and SK hynix announced the launch of the 'SK ICT Alliance' to jointly develop and invest in ICT convergence technologies, and create global market opportunities. Park...

2022-01-09 08:00 4937